3α-Hydroxy Pravastatin Sodium Salt (CAS 81093-43-8)
QUICK LINKS
3α-Hydroxy Pravastatin Sodium Salt functions as a competitive inhibitor of the enzyme HMG-CoA reductase. This inhibition leads to a decrease in the production of mevalonate, a precursor of cholesterol. By reducing cholesterol biosynthesis, 3α-Hydroxy Pravastatin Sodium Salt can potentially impact lipid metabolism and homeostasis. At the molecular level, 3α-Hydroxy Pravastatin Sodium Salt interacts with the active site of HMG-CoA reductase, preventing the conversion of HMG-CoA to mevalonate. This mechanism of action may be relevant in the study of lipid metabolism and the development of potential experimental models for investigating cholesterol-related pathways. 3α-Hydroxy Pravastatin Sodium Salt′s ability to modulate HMG-CoA reductase activity may offer insights into the regulation of cholesterol synthesis and its potential implications in cellular processes.
3α-Hydroxy Pravastatin Sodium Salt (CAS 81093-43-8) References
- Quantitative determination of pravastatin and its metabolite 3α-hydroxy pravastatin in plasma and urine of pregnant patients by LC-MS/MS. | Zhang, X., et al. 2016. Biomed Chromatogr. 30: 548-54. PMID: 26360932
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
3α-Hydroxy Pravastatin Sodium Salt, 1 mg | sc-216656 | 1 mg | $305.00 |